Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. (Q48349533)

10 February 2018

title

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. (English)

1 reference

10 February 2018

0 references

3

1 reference

10 February 2018

author name string

Heimberg C

1

1 reference

10 February 2018

Komoroski RA

2

1 reference

10 February 2018

Cardwell D

4

1 reference

10 February 2018

Karson CN

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

10 February 2018

published in

Psychiatry Research

1 reference

10 February 2018

volume

83

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

105-115

1 reference

10 February 2018

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Reproducibility of metabolite peak areas in 1H MRS of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Partial volume effects in volume-localized phased-array proton spectroscopy of the temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Automated single-voxel proton MRS: technical development and multisite verification

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

Raised monophosphatase activity in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900034-1

7 January 2021

10.1016/S0925-4927(98)00034-1

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9818736

1 reference

10 February 2018